INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M909. A total of 3 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $0 | -100.0% | 31 | +3.3% | 0.00% | – |
| Q1 2017 | $5,000 | – | 30 | +328.6% | 0.00% | – |
| Q4 2016 | $0 | – | 7 | -73.1% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 26 | -95.5% | 0.00% | -100.0% |
| Q2 2016 | $32,000 | +3.2% | 579 | +0.7% | 0.00% | 0.0% |
| Q1 2016 | $31,000 | – | 575 | +568.6% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 86 | +79.2% | 0.00% | – |
| Q3 2015 | $2,000 | -84.6% | 48 | -20.0% | 0.00% | -100.0% |
| Q2 2015 | $13,000 | – | 60 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 199 | $135,000 | 0.01% |
| SIMPLEX TRADING, LLC | 26 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 6,500 | $44,000 | 0.00% |